MSK_MT1_TBL2 (Pyrimidine&Purine Metabolism) Flashcards
N10- formyltetrahydrofolate.
AA required for purine de novo synthesis
GAG
- Glycine
- Aspartate
- Glutamine
Also requires:
- Folate derivative (Vit. B9)
- CO2
Pyrminidine Synthesis requires
- glutamine
- aspartate
- tetrahydrofolate
*
Difference between Cytosine (C) & Thyamine (T)
- one methyl group
![](https://s3.amazonaws.com/brainscape-prod/system/cm/354/215/765/a_image_thumb.jpeg?1629853046)
Difference between Cytosine (C) & Uracil (U)
At C-4 position, different group ( NH2 for Cystosine & C = O for Uracil)
- uracil is also only in RNA
![](https://s3.amazonaws.com/brainscape-prod/system/cm/354/215/914/a_image_thumb.jpeg?1629853298)
The Pyrimidines Basic Structure
![](https://s3.amazonaws.com/brainscape-prod/system/cm/354/216/639/a_image_thumb.jpeg?1629853766)
The Foundations of Pyrimidines
- Amide Donor (Glu)
- 1 C Donor (CO2 & TFH)
- 3 C & 1 N Donor (Asp)
- PRPP
![](https://s3.amazonaws.com/brainscape-prod/system/cm/354/217/002/a_image_thumb.jpeg?1629854258)
Pyrimidine Synthesis: Big Picture
Goals: TO CREATE
- CMP
- UMP
- TMP
From: Ribose phosphate via HMP shunt
Key points:
- UMP synthesized first
- UMP →→→ CMP & TMP
![](https://s3.amazonaws.com/brainscape-prod/system/cm/354/217/051/a_image_thumb.jpeg?1629854842)
Pyrimidine De Novo Synthesis: Step 1
Make carbamoyl phosphate via CPS-II
-
activated by PRPP and inhibited by UTP
- allosterically regulated by UTP (feedback inhibition)
- CPS-II = cytosolic
- uses Glutamine as N source
- rate-limiting step
- requires ATP
![](https://s3.amazonaws.com/brainscape-prod/system/cm/354/217/470/a_image_thumb.jpeg?1629855577)
Pyrimidine De Novo Synthesis: Step 2
Make Orotic Acid
- FIRST cyclic RING of pathway produced
![](https://s3.amazonaws.com/brainscape-prod/system/cm/354/218/354/a_image_thumb.jpeg?1629855928)
Pyrimidine De Novo Synthesis: Step 3
Make UMP
- Orotic Acid + PRPP = UMP
- UMP is the FIRST pyrimidine of pathway
- problems with enzyme UMP Synthase = Oroticaciduria
- due to the accumulation of Orotic Acid that cant be converted to UMP
![](https://s3.amazonaws.com/brainscape-prod/system/cm/354/218/398/a_image_thumb.jpeg?1629856795)
Orotic Aciduria-UMP Synthase Deficiency
Symptoms:
- leads to orotic aciduria = ↑↑↑ orotic acid in urine
- megaloblastic anemia (large/not functional RBC)
- growth retardation
- cognitive disabilities
- renders both OPRT and OMP decarboxylase DYSFUNCT.
- no B12/Folate Response (i.e normal anemia treatment does not work… suggests UMP Synthase Deficiency)
Treatment:
- oral Uridine therapy (by pass the Synthase)
Inherited Disorders of Pyrimidine Nucleotide Metabolism
- Orotic Aciduria
-
pyrimidine 5’-nucleotidase deficiency
* ↑↑↑ blood pyrimidine ribonucleotides - OTC
Ornithine Transcarbamlyase Deficiency (OTC)
- to do with the UREA CYCLE but still makes impact
- From the UREA CYCLE, we get EXCESS of carbamoyl phosphate which gets converted into an EXCESS of Orotic acid
![](https://s3.amazonaws.com/brainscape-prod/system/cm/354/219/938/a_image_thumb.jpeg?1629858864)
Pyrimidine De Novo Synthesis: Step 4
Make UDP/UTP
- revsible rxns
- carried out by kinases (that add P)
![](https://s3.amazonaws.com/brainscape-prod/system/cm/354/221/137/a_image_thumb.png?1629859158)
Pyrimidine De Novo Synthesis: Step 5
Convert UTP → CTP
- catalyzed by CTP synthetase: transaminates C= O → NH2 (donated from GLUTAMINE)
- inhibited by CTP (feedback inhibition)
- UTP & CTP make RNA
![](https://s3.amazonaws.com/brainscape-prod/system/cm/354/221/185/a_image_thumb.jpeg?1629859778)
Pyrimidine De Novo Synthesis: Step 6
CDP → dCDP
- ribonucleotide reductase = deoxygenates
- Clinical Correlation:*
HYDROXYUREA = a drug that inhibits reductase so no dCDP is made
![](https://s3.amazonaws.com/brainscape-prod/system/cm/354/222/097/a_image_thumb.jpeg?1629860792)
Thymidine
- Only Used in DNA
- Deoxythymidine is only required nucleotide
- Synthesized from deoxyuridine